Ophthalmology

Ophthalmology Therapeutic Portfolio

Ophthalmology focuses on the diagnosis of eye diseases and vision problems, the management of various medical eye conditions, and eye surgery. This medical specialty covers the complete visual system, including routine eye care. Our ophthalmology therapeutic portfolio includes a range of ocular anti-infective, anti-inflammatory, anti-allergy and glaucoma products, together with selected products for perioperative ophthalmic use. Two key portfolio groups of ophthalmic drops are as follows:

The above ophthalmological drugs, particularly those included in the list of ophthalmic drops, may be used in a range of medical and perioperative ophthalmic settings according to their locally authorised indications.

Institutional Applications & Demand Drivers

Demand for ophthalmology medicines is influenced by the continuing need to manage chronic eye conditions and by the established role of topical, non-invasive ophthalmic products in clinical practice.. Demand for ophthalmologic drops is influenced by factors such as population ageing and the continuing need to manage eye conditions including glaucoma and cataracts.. We deliver our products to hospitals, specialized eye centres, and surgery clinics, where selected eye drops may be used before or after ophthalmic procedures according to their authorised indications.. We also cooperate with emergency & urgent care facilities where ophthalmic antibiotics may be used for the initial management of bacterial eye conditions when clinically indicated.. Our assortment includes prescription institutional medicines such as anti-glaucoma drops, together with ophthalmology medications intended for infectious and inflammatory eye conditions.

Dosage Forms, Strengths & Packaging Options

As an ophthalmic solutions manufacturer, Farmak International offers sterile eye-drop solutions and suspensions in different concentrations and pack sizes, subject to product-specific availability.. Our assortment includes eye drops in different concentrations and liquid volumes, including multidose formats where specified in the relevant product documentation.. We offer dropper bottles designed to support consistent drop delivery and protect the contents from microbial contamination when stored and used according to the relevant product instructions..

We havewarehouses that operate in accordance with applicable Good Distribution Practice requirements. Controlled storage conditions, including cold-chain handling where required, are used to maintain product quality throughout the supply chain.. We invite our partners to request information about ophthalmic medications for hospitals and other healthcare facilities, including available formulations, dossier status and supply options.

Quality, Safety & Compliance Framework

We conduct in-process quality checks and test our products in Farmak laboratories in accordance with applicable GMP requirements for medicinal-product manufacturers, including ophthalmology product manufacturers. To support the quality and regulatory compliance of finished products, we apply strict controls to the raw materials used in their manufacture, packaging materials and other related components.

Farmak International manufactures and tests relevant products according to applicable pharmacopoeial requirements and holds a range of national and international certifications supported by regulatory and partner audits.. Farmak International’s manufacturing quality system is supported by EU GMP certifications from the relevant Spanish, Polish and Croatian authorities, as well as additional GMP certification from the Ukrainian regulatory authority.. We also hold relevant certification from the Saudi Food and Drug Authority and have received JIPM TPM Excellence recognition.

Farmak International’s Role as a Trusted B2B Supplier of Ophthalmology Medicines

Farmak International works with international partners, supporting access to ophthalmic drug treatments via B2B supply-chain distribution of relevant medicinal products. We support stable product availability for hospitals and eye centres worldwide and offer tailored solutions for institutional procurement and tender requirements, subject to registration status, production capacity and agreed supply conditions.

We develop medicines across various therapeutic areas. Every year, we submit 10+ new CTD dossiers, giving our partners access to an expanding portfolio. We coordinate export-licensing processes and international transportation and provide regulatory, dossier and technical documentation support.